(Q54606960)
Statements
A phase I/IIa clinical trial of a recombinant Rho protein antagonist in acute spinal cord injury. (English)
James Harrop
Gilles Maurais
Charles Kuntz
Chris I Shaffrey
Brian K Kwon
Jens Chapman
Albert Yee
Allyson Tighe
Lisa McKerracher
1 May 2011
28
5
787-796